Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

OncoSil Medical (ASX:OSL) Is Rallying — What Should Investors Know About This Cancer Treatment Biotech?

OncoSil Medical presented updated results from its TRIPP-FFX study at ESMO GI 2026, the European Society for Medical Oncology's Gastrointestinal Cancers Congress, held in Munich, Germany. According to the company, the data were delivered on 6 July 2026 as a Rapid Oral Presentation by …

Sonal Goyal | 23 July 2026

Ramsay Health Care (ASX:RHC) Trades Lower Today — What Investors Should Know About the Hospital Group

With a market capitalisation of approximately AUD 9.77 billion, Ramsay Health Care Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

ResMed (ASX:RMD) Moves Lower Today — Is the Sleep Apnoea Giant Still Worth Watching?

With a market capitalisation of approximately AUD 16.36 billion, ResMed Inc is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

Ryman Healthcare (ASX:RYM) Is Gaining Today — Should Investors Take a Fresh Look at the Aged Care Provider?

With a market capitalisation of approximately AUD 1.90 billion, Ryman Healthcare Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

Sigma Healthcare (ASX:SIG) Edges Lower — Is the Pharmacy Distribution Giant Still a Story Worth Following?

With a market capitalisation of approximately AUD 33.13 billion, Sigma Healthcare Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

TELIX Pharmaceuticals (ASX:TLX) Is Up Today — Is the Radiopharmaceutical Company Worth a Closer Look?

With a market capitalisation of approximately AUD 5.15 billion, TELIX Pharmaceuticals Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

Neuren Pharmaceuticals (ASX:NEU) Falls Today — What's Behind the Rare Neurological Disease Biotech?

With a market capitalisation of approximately AUD 2.09 billion, Neuren Pharmaceuticals Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

Pro Medicus (ASX:PME) Is Down Sharply Today — Should Investors Reassess the Medical Imaging Software Leader?

With a market capitalisation of approximately AUD 16.94 billion, Pro Medicus Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

Polynovo (ASX:PNV) Falls Back Today — Is the Wound Care Biotech Still a Compelling Long-Term Story?

With a market capitalisation of approximately AUD 639.03 million, Polynovo Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026

PYC Therapeutics (ASX:PYC) Is Up Today — Is This RNA Therapeutics Biotech Worth Watching?

With a market capitalisation of approximately AUD 1.65 billion, PYC Therapeutics Ltd is among the companies reflected in the S&P/ASX 200 Health Care Index, which tracks major healthcare-related businesses listed on the Australian Securities Exchange.

Sonal Goyal | 23 July 2026
Support

Hi! How can we help you today?

Loading…